UCL-led trial shows adding niraparib to standard therapy reduces tumour growth risk in men with advanced prostate cancer by up to 37%, with greater effect in specific genetic subgroups.
Professor Pierre Ronco and Dr Hanna Debiec discuss the viability of precision medicine in treating patients with the rare disease membranous nephropathy
Assistant Professor Clare Kirkpatrick shares insight into the development of new antibiotics for the opportunistic human pathogen, Pseudomonas aeruginosa
Dr Doug Brown, Director of Research, Alzheimer’s Society provides details on the research into vascular dementia and explains why more work is needed
Vascular dementia...
British Lung Foundation’s Dr Penny Woods provides advice on how to manage a respiratory condition and highlights the strides being made into lung research
Professor Colin J Suckling explains how teams at the University of Strathclyde and University of Glasgow are challenging global parasitic infection
Cows, horse, camels
When people...
Ai-Ling Lin PhD, of The Lin Brain Lab talks about the reversal of cognitive decline in Alzheimer’s disease with comprehensive and personalised nutrition
Alzheimer’s disease...
